Influenza vaccine quadrivalent (Livzon Pharma)

四价流感重组蛋白疫苗（丽珠医药）

Report date: 2025/09/11 17:56:13

Base Information

Drug NameInfluenza vaccine quadrivalent (Livzon Pharma)

Drug Alias NameLZSN2401

ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesLivzon Pharmaceutical Group Inc

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesLivzon Pharmaceutical Group Inc

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A